Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | RAB9A | P51151 | 3/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | NCF1 | P14598 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14700561 | 0.89 | CRHR1 (0.32) | CRHR1 | |
| SCHEMBL13090403 | 0.85 | CYP1A2 (0.38) | ADORA2AADORA1ADORA2BCYP1A2KDM4E | |
| SCHEMBL10015419 | 0.81 | MEN1 (0.35) | ADORA2AADORA1CYP1A2KDM4EALDH1A1 | |
| SCHEMBL14139825 | 0.78 | KDM4E (0.34) | ADORA2AADORA1KDM4EALDH1A1HPGD | |
| SCHEMBL14139827 | 0.78 | KDM4E (0.34) | ADORA2AADORA1KDM4EALDH1A1HPGD | |
| SCHEMBL14139948 | 0.78 | ALDH1A1 (0.38) | ADORA2ACYP1A2KDM4EALDH1A1HPGD | |
| SCHEMBL14139947 | 0.78 | ALDH1A1 (0.38) | ADORA2ACYP1A2KDM4EALDH1A1HPGD | |
| SCHEMBL14139986 | 0.77 | HSD17B1 (0.41) | ADORA1CYP1A2MEN1KMT2A | |
| SCHEMBL14139988 | 0.77 | HSD17B1 (0.41) | ADORA1CYP1A2MEN1KMT2A | |
| SCHEMBL25005766 | 0.76 | MEN1 (0.36) | CYP1A2RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190245152-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-08-08 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | CRHR1 616/4885ADORA2A 1440/4885ADORA1 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.